U.S. Food and Staples Retail Stock News

Iovance Biotherapeutics recently received conditional approval from Australia’s Therapeutic Goods Administration for its advanced melanoma cell therapy Amtagvi, marking its third global marketing authorization after the US and Canada. This milestone opens access to the world’s highest-melanoma-rate market and aligns with Iovance’s broader efforts to expand international commercialization of its TIL-based therapies. We’ll now examine how entering Australia’s high-melanoma market could...

Molson Coors Beverage (TAP) is back in focus after recent share price moves left the stock down about 17% year to date and about 11% over the past 12 months, prompting fresh interest in its valuation. See our latest analysis for Molson Coors Beverage. At a latest share price of US$40.54, Molson Coors Beverage has seen short term share price momentum soften, with the 30 day return down 1.67% and the 90 day return down 6.59%, while the 1 year total shareholder return is down 10.5%. This points...

H.B. Fuller (FUL) has just posted Q2 2026 results with revenue of US$950.3 million, Basic EPS of US$1.25 and net income excluding extra items of US$67.8 million, giving investors a clear look at how the business is performing at mid year. The company has seen quarterly revenue move from US$898.1 million in Q2 2025 to US$950.3 million in Q2 2026, while Basic EPS shifted from US$0.77 to US$1.25 over the same period. This sets the stage for investors to focus on how these results feed through to...

Polaris (NYSE:PII) has secured long-term funding dedicated to outdoor recreation initiatives across America's National Forests. The company announced that its Polaris Fund for Outdoor Recreation Grants is now fully endowed, providing ongoing support for conservation, access, and stewardship projects. Polaris also appointed Dustin J. Semach to its Board of Directors, adding industry and financial experience at an important moment for its governance. Polaris, known for its off-road vehicles,...

In June 2026, IMU Biosciences announced a partnership with Waters Corporation to combine Waters Biosciences' advanced flow cytometry and single‑cell platforms with IMU's AI‑driven High Definition Immunology analytics to enable real‑time, large‑scale immune system profiling across research and clinical settings. This collaboration aims to help establish a universal standard for immune profiling by pairing Waters' hardware and reagents with IMU's machine‑learning platform and expanding IMU's...

If you are trying to work out whether Vornado Realty Trust at around US$38 per share looks expensive or appealing, the key question is how its current price stacks up against a fair value estimate. The stock has recent returns of 0.7% over 7 days, 16.5% over 30 days, 13.8% year to date, 4.8% over 1 year, a very large gain over 3 years and a 5.0% decline over 5 years, which gives a mixed picture of momentum and risk. Recent news around office real estate, including ongoing debate about long...

Major long-term institutional investors, including Berkshire Hathaway and Appaloosa Management, have exited or cut positions in UnitedHealth Group (NYSE:UNH). These moves come as UnitedHealth Group plans to reduce Medicare Advantage membership by 2 million to 3 million lives. The membership pullback follows negative federal oversight findings related to care and claim denials within Medicare Advantage. UnitedHealth Group sits at the center of US managed care, with Medicare Advantage a key...

Earlier in 2026, CarGurus, the most visited automotive shopping site in the U.S., released its Mid-Year Review showing resilient consumer demand, with full-size luxury SUVs above US$80,000 selling faster than the average new vehicle and used hybrids seeing strong year-to-date sales and record prices. The report highlights a shift in buyer preferences toward high-priced luxury SUVs and efficiency-focused used hybrids, underlining how changing consumer mix is reshaping inventory turnover and...

Earlier this week, UMH Properties, Inc. voiced strong support for the bipartisan 21st Century ROAD to Housing Act, highlighting provisions such as removing the permanent chassis requirement, updating FHA Title I financing, and easing zoning barriers for manufactured housing. The company’s leadership framed this legislation as a potential catalyst for expanding its manufactured home communities and enhancing housing options for American families, which could be particularly relevant for...

Earlier this week, ARS Pharmaceuticals reported that neffy, its epinephrine nasal spray, did not gain any new major commercial insurance coverage in the July 1, 2026 review cycle, though the company did secure additional Medicaid coverage and reduced its planned 2026 cash-based operating expenses. The update also included management’s reaffirmation that the existing neffy business underpins a path to cash-flow break-even in 2027, underscoring how payer access remains central to the company’s...

Moog (MOG.A) is in focus after reporting quarterly results that exceeded analyst expectations on both revenue and earnings, with leadership describing record financial performance and stronger execution across the business. See our latest analysis for Moog. Moog’s recent earnings surprise has come alongside strong share price momentum, with a 30-day share price return of 21.5% and a year-to-date share price return of 66.6%, while the 1-year total shareholder return of 127.6% points to...

In June 2026, Helus Pharma reported that enrollment in Cybin’s APPROACH Phase 3 trial of HLP003 for adjunctive major depressive disorder surpassed 86%, advancing a program that holds FDA Breakthrough Therapy Designation and builds on earlier positive Phase 2 clinical outcomes. This late-stage progress, alongside previously reported long-term efficacy signals, highlights how HLP003 could further shape Cybin’s pipeline profile if Phase 3 results are supportive. We’ll now examine how this...

Shake Shack (SHAK) has drawn investor attention after recent share price weakness, with the stock down 11% over the past month and 32% over the past 3 months, alongside ongoing revenue and net income growth. See our latest analysis for Shake Shack. Looking past the recent pullback, Shake Shack’s share price has fallen 33.84% year to date and the 1 year total shareholder return is down 60.11%, signaling fading momentum. If Shake Shack’s recent volatility has you rethinking where growth could...

If you are wondering whether Procter & Gamble stock is offering fair value or a potential discount right now, the starting point is understanding how its current price lines up against several valuation checks. The share price recently closed at US$148.50, with returns that include a decline of 1.3% over the past week but gains of 3.9% over the past month and 4.7% year to date, alongside a decline of 3.7% over the last year. Recent coverage has focused on how Procter & Gamble fits into...

Space Exploration Technologies (SPCX) has drawn investor attention after recent trading left the stock down 1% on the day and about 17% over the past week, sharpening focus on its current fundamentals. See our latest analysis for Space Exploration Technologies. With the share price at $153.0, Space Exploration Technologies has seen its 1-day share price return decline 1% and its 7-day share price return fall 17.3%, leaving the year-to-date share price return down 4.9% and indicating that...

Uber Technologies (NYSE:UBER) plans to launch its first robotaxi pilot in Spain with WeRide. Uber is also preparing to expand autonomous ride services in Zurich, Switzerland. The initiatives extend Uber’s commercial autonomous rollout beyond the U.S. and Middle East into European markets. Uber is coordinating with partners including Wayve and Stellantis to deploy Level 4 autonomous vehicles across multiple regions. Uber Technologies sits at the center of app based ride hailing, food...

Applied Materials (NasdaqGS:AMAT) has introduced a new suite of chipmaking systems focused on advanced 3D chip architectures for AI. The platforms target high bandwidth memory, 3D DRAM structures, advanced packaging, and process control for AI focused chips. The launch comes as industry peers highlight ongoing supply constraints and AI related memory shortages. Applied Materials aims to support both front end transistor performance and back end chip stacking and packaging for AI...

SM Energy (SM) has drawn investor attention after a sharp share price pullback, with the stock down about 17% over the past month and nearly 19% over the past 3 months. See our latest analysis for SM Energy. Zooming out, SM Energy’s recent pullback contrasts with its stronger year to date share price return of 38.63% and a 1 year total shareholder return of 8.8%. Together, these figures indicate that momentum has faded after a stronger run earlier in the year. If you are considering other...

Vishay Intertechnology (VSH) has introduced the VOLA617A optocoupler, targeting high galvanic isolation for 800 V electric vehicle battery systems and industrial automation, a development that could influence how some investors view the stock. See our latest analysis for Vishay Intertechnology. The recent product launches in EV and industrial components come as Vishay Intertechnology’s share price has delivered very strong momentum, with a 30 day share price return of 18.94% and a year to...

Innoviva, Inc. recently launched Nortiva Bio, a wholly owned clinical-stage subsidiary built around the LYNX long-acting oral drug delivery platform acquired from Lyndra Therapeutics in 2025, and Innoviva Specialty Therapeutics signed an exclusive agreement with Dr. Reddy's Laboratories to distribute and license XACDURO in selected international markets. Together, these moves broaden Innoviva's exposure to advanced drug delivery technologies while extending the commercial footprint of its...

Hershey (NYSE:HSY) has appointed Heather Hoytink as President, U.S. Hoytink joins Hershey after a high-profile sales and commercial leadership career at PepsiCo. The appointment puts a new leader in charge of Hershey’s core U.S. business, which drives a large share of its revenue and product activity. For investors tracking Hershey at a share price of $176.68, this leadership change lands at a time when the stock has delivered mixed returns. HSY is up 2.3% over the past week and 9.0% over...

In recent months, analysts have highlighted Medtronic’s progress in its Symplicity Spyral renal denervation system, which already has FDA approval and is on track for Medicare coverage beginning in October 2025, supporting expectations for stronger demand in hypertension treatment. This focus on renal denervation complements Medtronic’s broader push into high-need areas such as cardiac ablation and diabetes care, reinforcing its position in complex chronic disease management. Next, we’ll...

Earlier this month, Nextpower announced the global launch of its reimagined NX Gemini two-in-portrait solar tracker system and NX Anchor integrated foundation solution, expanding its high-density solar tracking, foundation, and software portfolio across Europe and supporting complex projects like Greece’s Ptolemaida Solar Park. This push into advanced tracker controls, integrated foundations, and agriPV-focused operating modes signals a broader move to make more challenging European sites...

Earlier this month, Fifth Third Bancorp launched an AI-powered experience within its mobile app, allowing users to type natural-language requests like “replace card” or “transfer funds” and be routed directly to the most relevant digital tool, chatbot, or human support. By training the system on hundreds of millions of past interactions and achieving about 90% intent recognition in its Jeanie chatbot, the bank is turning its high-volume mobile traffic into a feedback loop that continuously...